Peter Kolchinsky and his hedge fund, RA Capital Management, boosted their position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) to 21.2%, a filing with the SEC showed. RA now holds around 20.5 million shares of Achillion, up from 19.3 million disclosed in an earlier form 4 filing.
Disclosure: none
Recommended Reading:
Paul Singer’s Elliott Management Reports a 2.9% Stake in National Bank Holdings
Fairfax Still Silent About BlackBerry With Deadline Approaching
Richard Perry’s Perry Corp Decreases Stake in North American Energy Partners